Stockscreener 앱 받기
44.55
0.09%
-0.04
전일 마감가:
$44.59
열려 있는:
$44.6
하루 거래량:
1.19M
Relative Volume:
0.40
시가총액:
$37.07B
수익:
$27.43B
순이익/손실:
$1.27B
주가수익비율:
28.14
EPS:
1.5829
순현금흐름:
$1.01B
1주 성능:
-5.81%
1개월 성능:
+3.97%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$44.03
$45.43
1주일 범위
$43.57
$47.88
52주 변동 폭
$38.50
$47.99
Medline Inc Stock (MDLN) Company Profile
Compare MDLN vs ISRG, BDX, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
44.55 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ISRG
Intuitive Surgical Inc
|
485.84 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
175.89 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.20 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.55 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-05 | 개시 | Tigress Financial | Buy |
| 2026-01-21 | 재확인 | BTIG Research | Buy |
| 2026-01-12 | 개시 | Citigroup | Buy |
| 2026-01-12 | 개시 | Deutsche Bank | Hold |
| 2026-01-12 | 개시 | Evercore ISI | Outperform |
| 2026-01-12 | 개시 | Goldman | Buy |
| 2026-01-12 | 개시 | JP Morgan | Overweight |
| 2026-01-12 | 개시 | Jefferies | Buy |
| 2026-01-12 | 개시 | Leerink Partners | Outperform |
| 2026-01-12 | 개시 | Mizuho | Outperform |
| 2026-01-12 | 개시 | Morgan Stanley | Overweight |
| 2026-01-12 | 개시 | Piper Sandler | Overweight |
| 2026-01-12 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-12 | 개시 | Robert W. Baird | Outperform |
| 2026-01-12 | 개시 | Rothschild & Co Redburn | Neutral |
| 2026-01-12 | 개시 | Stifel | Buy |
| 2026-01-12 | 개시 | TD Cowen | Buy |
| 2026-01-12 | 개시 | Truist | Buy |
| 2026-01-12 | 개시 | UBS | Buy |
| 2026-01-12 | 개시 | Wells Fargo | Equal Weight |
| 2026-01-12 | 개시 | William Blair | Outperform |
| 2026-01-12 | 개시 | Wolfe Research | Outperform |
모두보기
Medline Inc 주식(MDLN)의 최신 뉴스
FDA Flags Serious Safety Fire Risks In Medline Homecare Beds - Benzinga
Is It Too Late To Consider Medline (MDLN) After Its Recent Share Price Rally? - Yahoo Finance
Medline stock pops 40% in first trading session after company raises $6.3 billion in 2025's biggest IPO - AOL.com
Evaluating Medline (MDLN) After Recent Share Price Momentum And A 31.1x P/E Multiple - Sahm
Medline Inc. (MDLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Medline Inc.Class A common stock (NQ: MDLN - FinancialContent
MDLN Medline Inc. Feb 2026 Tigress Financial Initiates Coverage with Buy - Meyka
Tigress Financial initiates Medline stock with Buy rating, $55 target By Investing.com - Investing.com Nigeria
Tigress Financial initiates Medline stock with Buy rating, $55 target - Investing.com
Jim Boyle: 100 Most Influential People in Healthcare 2025 - Modern Healthcare News
Medline (NASDAQ:MDLN) Now Covered by Analysts at Tigress Financial - MarketBeat
Tigress Initiates Medline at Buy With $55 Price Target - marketscreener.com
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio - The Motley Fool
Wash. Justices Won't Hear Medline's $2.4M Refund Request - Law360
Medline CEO Jim Boyle talks record IPO and AI plans with hospitals - Crain's Chicago Business
Medline’s Jim Boyle talks record IPO, AI plans with hospitals - Modern Healthcare News
Medline to report fourth quarter and full year 2025 results on February 25, 2026 - GlobeNewswire
Is It Time To Reassess Medline (MDLN) After Its Recent Share Price Climb - Yahoo Finance
Medline Inc (MDLN) Shares Up 3.65% on Jan 22 - GuruFocus
Jim Cramer says Medline stock is unbelievable and recommends buying it - MSN
Jim Cramer Says Medline "Stock Is Unbelievable" And Recommends Buying It - Finviz
Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It - Yahoo Finance
Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway (NASDAQ:MDLN) - Seeking Alpha
Jim Cramer Recently Looked at These 25 Stocks - Insider Monkey
Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results - Sahm
Pointcore Supply Chain Services members select Medline as distributor - Medline Newsroom
Ranpak expands packaging automation partnership with Medline - Packaging Insights
In face of uncertainty and tariffs, newly public Medline sticks to the old formula - Crain's Chicago Business
Ranpak and Medline deepen packaging automation collaboration - Yahoo Finance
Ranpak in Collaboration with Medline - Medical Device and Diagnostic industry
Medline Shares Climb as Analysts Launch Coverage After $7.2 Bill - GuruFocus
Medline Shares Climb as Analysts Launch Coverage After $7.2 Billion IPO - Yahoo Finance
Ranpak and Medline Partner to for High-Volume Distribution Operations From: Ranpak Corporation - Healthcare Packaging
Ranpak Holdings Corp. and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - marketscreener.com
Ranpak and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Medline jumps as analysts bullish after 2025’s top IPO - The Daily Gazette
Medline Jumps as Analysts Bullish After 2025’s Top IPO - Bloomberg
Analysts initiate coverage on Medline after IPO, flag growth visibility and margin - Investing.com
Why Is Medline Stock Gaining Monday?Medline (NASDAQ:MDLN) - Benzinga
Analysts Say Medline Has The Secret Sauce For Sustained Growth - Sahm
Is Medline (MDLN) Fairly Priced After Recent Share Price Stability? - Yahoo Finance
Analysts initiate Medline with bullish ratings after blockbuster IPO - Reuters
TD Cowen initiates Medline stock with Buy rating on market share growth - Investing.com Nigeria
BTIG initiates coverage on Medline stock with Buy rating, $50 target By Investing.com - Investing.com South Africa
Wells Fargo & Company Begins Coverage on Medline (NASDAQ:MDLN) - MarketBeat
This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Medline initiated with a Buy at BTIG - TipRanks
Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target - marketscreener.com
BMO Capital Initiates Coverage on Medline With Outperform Rating, $45 Price Target - marketscreener.com
Medline Inc (MDLN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.78%
1.08%
자본화:
|
볼륨(24시간):